User profiles for G. Dervenoulas

George Dervenoulas

King's College London
Verified email at kcl.ac.uk
Cited by 1090

[HTML][HTML] Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment

A Chandra, G Dervenoulas, M Politis… - Journal of …, 2019 - Springer
Research utilizing magnetic resonance imaging (MRI) has been crucial to the understanding
of the neuropathological mechanisms behind and clinical identification of Alzheimer’s …

Advances in MRI methodology

T Yousaf, G Dervenoulas, M Politis - International review of neurobiology, 2018 - Elsevier
G z , G y and G x signify the magnetic field gradients in the slice-select, phase-encoding
and frequency-encoding directions, respectively. Apparent diffusion coefficient (ADC) signifies …

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment

…, G Pagano, O Cousins, G Dervenoulas… - Human brain …, 2019 - Wiley Online Library
Alzheimer's disease (AD) is a devastating and progressive neurodegenerative disease for
which there is no cure. Mild cognitive impairment (MCI) is considered a prodromal stage of the …

Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo11C-BU99008 PET study

H Wilson, G Dervenoulas, G Pagano, RJ Tyacke… - Brain, 2019 - academic.oup.com
Astroglia are multifunctional cells that regulate neuroinflammation and maintain homeostasis
within the brain. Astroglial α-synuclein-positive cytoplasmic accumulations have been …

Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study

H Wilson, G Dervenoulas, G Pagano, C Koros… - The Lancet …, 2019 - thelancet.com
Background Because of the highly penetrant gene mutation and clinical features consistent
with idiopathic Parkinson's disease, carriers of the autosomal dominant Ala53Thr (A53T; …

[HTML][HTML] Neuroimaging in Lewy body dementia

T Yousaf, G Dervenoulas, PE Valkimadi, M Politis - Journal of neurology, 2019 - Springer
Lewy body dementia (DLB) is a common form of cognitive impairment, accounting for 30%
of dementia cases in ages over 65 years. Early diagnosis of DLB has been challenging; …

Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrum

A Chandra, C Farrell, H Wilson, G Dervenoulas… - Neurobiology of …, 2021 - Elsevier
Clearance of amyloid-β (Aβ) from the brain is hypothesized to be mediated by the glymphatic
system through aquaporin-4 (AQP4) water channels. Genetic variation of AQP4 may impact …

Double seronegative myasthenia gravis with low density lipoprotein-4 (LRP4) antibodies presenting with isolated ocular symptoms

G Tsivgoulis, G Dervenoulas, P Kokotis… - Journal of the …, 2014 - Elsevier
… Author links open overlay panel Georgios Tsivgoulis a b , Georgios Dervenoulas a ,
Panagiotis Kokotis a c , Christina Zompola a , John S. … Dr Dervenoulas reports no disclosures. …

[HTML][HTML] [18F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis

A Carotenuto, B Giordano, G Dervenoulas… - European Journal of …, 2020 - Springer
… George Dervenoulas … CBF is measured in ml/100 g/min. … Klunk WE, Engler H, Nordberg
A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with …

Structural magnetic resonance imaging in Huntington's disease

H Wilson, G Dervenoulas, M Politis - International review of neurobiology, 2018 - Elsevier
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder, caused
by expansion of the CAG repeat in the huntingtin gene. HD is characterized clinically by …